Nelson Rodrigues
Researcher/clinician in the Mood Disorders Psychopharmacology Unit at the University Health Network and University of Toronto
Papers
Trials
Key Impact
He is a recurring author on ketamine and esketamine studies, including systematic reviews and real-world clinical effectiveness research relevant to suicidality and treatment-resistant depression.
Background & Research
Nelson B. Rodrigues is a researcher associated with the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto and the University of Toronto. His published work centers on ketamine and other rapid-acting treatments for mood disorders, with interests spanning suicidality, treatment response, sleep, and real-world outcomes. He has coauthored systematic reviews and clinical studies on ketamine/esketamine in depression and related psychiatric conditions.
Collaboration Network
28 collaborators· click a node to visit their profile
Full network →